Maximizing Shared Research Resources-ROI

Sheenah Mische, NYU Langone School of Medicine

Shared research resources – from high tech core facilities to living collections and national laboratories – broaden researchers’ access to advanced technologies and materials and make efficient use of institutional space and funds. The return on investment includes financial – economies of scale, maximizing use of space, centralized institutional knowledge – but also included benefits that do not have measurable financial gains, such as faculty recruitment and retainment, improved grant success, publications, and institutional reputation. 

Learning Objectives

  • Understand space planning considerations for current and future needs for the implementation and dissemination of novel technology and expertise in support of scientific innovation and education.
  • Understand establishing business planning for the effective operation of shared resource core laboratories.
  • Understand employing non-financial metrics for evaluating the performance and the Balanced Score Card (Kaplan and Norton), as a tool for calculating the return on institutional investment (ROI).
  • Understand establishing an effective review cycle for evaluating shared resource performance and goal setting aligned with institutional strategic vision.


Sheenah Mische is Senior Director of the Division of Advanced Research Technologies (DART) and Associate Professor of Pathology at NYU Langone School of Medicine.  In her role she provides oversight for all scientific shared resource cores, supporting collaborative translational interdisciplinary research.   Sheenah has 30+ years of executive leadership in academia and industry, integrating multidisciplinary teams and strategic technology investment to drive innovation and collaborations.  Before joining NYU Langone, she was Director of Translational Sciences and Director of Protein Resources for Boehringer Ingelheim Pharmaceuticals.  Prior to that she was Director of the Rockefeller University Technology Center.   She received her MS in Biochemistry from NYU and PhD in Experimental Pathology from Yale University.   She serves on the Board of Directors for the Federation of American Scientists and Experimental Biologists (FASEB), chairs the FASEB Shared Research Resources Subcommittee, and is a member of the Association of Biomolecular Facilities (ABRF), serving on the Executive, Career Development, Education and Core Rigor and Reproducibility Committees.


Note: I2SL did not edit or revise abstract or biography text. Abstracts and biographies are displayed as submitted by the author(s).